Sulzer Inter-Op Hip Shell Loosening Detected In 129 Patients Following Recall
This article was originally published in The Gray Sheet
Executive Summary
The financial impact of Sulzer Orthopedics' Inter-Op acetabular shell hip implant recall Dec. 5 "will be more than offset" by a $32 mil. one-time payment from a separate litigation settlement to its Sulzer Spine-Tech subsidiary, the firm predicts.
You may also be interested in...
Centerpulse/Sulzer Cuts Settlement Opt-Outs To 87, Sidesteps Bankruptcy
Centerpulse plans to "aggressively defend" in court any outstanding claims related to its Inter-Op hip implant and Natural Knee II recalls that were not part of a class settlement, but the firm has not ruled out the possibility of settling those claims out of court
Sulzer Changes Name To Centerpulse, Will Approve Class Settlement May 22
Sulzer Medica will attempt to reduce the financial impact of 132 opt-out cases from its class action settlement, reiterating that the firm may file for Chapter 11 bankruptcy to avoid settling those claims
Sulzer Changes Name To Centerpulse, Will Approve Class Settlement May 22
Sulzer Medica will attempt to reduce the financial impact of 132 opt-out cases from its class action settlement, reiterating that the firm may file for Chapter 11 bankruptcy to avoid settling those claims